124 related articles for article (PubMed ID: 24563116)
1. Antitumor effect of TRAIL on oral squamous cell carcinoma using magnetic nanoparticle-mediated gene expression.
Miao L; Liu C; Ge J; Yang W; Liu J; Sun W; Yang B; Zheng C; Sun H; Hu Q
Cell Biochem Biophys; 2014 Jul; 69(3):663-72. PubMed ID: 24563116
[TBL] [Abstract][Full Text] [Related]
2. Antitumor effect of human TRAIL on adenoid cystic carcinoma using magnetic nanoparticle-mediated gene expression.
Miao L; Zhang K; Qiao C; Jin X; Zheng C; Yang B; Sun H
Nanomedicine; 2013 Jan; 9(1):141-50. PubMed ID: 22633896
[TBL] [Abstract][Full Text] [Related]
3. Efficient miRNA Inhibitor Delivery with Graphene Oxide-Polyethylenimine to Inhibit Oral Squamous Cell Carcinoma.
Ou L; Sun T; Liu M; Zhang Y; Zhou Z; Zhan X; Lu L; Zhao Q; Lai R; Shao L
Int J Nanomedicine; 2020; 15():1569-1583. PubMed ID: 32210552
[TBL] [Abstract][Full Text] [Related]
4. Synergistic antitumor effect of AAV-mediated TRAIL expression combined with cisplatin on head and neck squamous cell carcinoma.
Jiang M; Liu Z; Xiang Y; Ma H; Liu S; Liu Y; Zheng D
BMC Cancer; 2011 Feb; 11():54. PubMed ID: 21291526
[TBL] [Abstract][Full Text] [Related]
5. [Effects of human telomerase reverse transcriptase promoter and survivin promoter in targeted tumor gene therapy].
Zhang Y; Ma H; Liu SL; Liu YX; Zheng DX
Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(7):475-9. PubMed ID: 18642790
[TBL] [Abstract][Full Text] [Related]
6. The efficacy of combination therapy using adeno-associated virus-TRAIL targeting to telomerase activity and cisplatin in a mice model of hepatocellular carcinoma.
Wang Y; Huang F; Cai H; Wu Y; He G; Tan WS
J Cancer Res Clin Oncol; 2010 Dec; 136(12):1827-37. PubMed ID: 20213096
[TBL] [Abstract][Full Text] [Related]
7. Codelivery of doxorubicin and MDR1-siRNA by mesoporous silica nanoparticles-polymerpolyethylenimine to improve oral squamous carcinoma treatment.
Wang D; Xu X; Zhang K; Sun B; Wang L; Meng L; Liu Q; Zheng C; Yang B; Sun H
Int J Nanomedicine; 2018; 13():187-198. PubMed ID: 29343957
[TBL] [Abstract][Full Text] [Related]
8. Multifunctionalized polyethyleneimine-based nanocarriers for gene and chemotherapeutic drug combination therapy through one-step assembly strategy.
Jiang D; Wang M; Wang T; Zhang B; Liu C; Zhang N
Int J Nanomedicine; 2017; 12():8681-8698. PubMed ID: 29263663
[TBL] [Abstract][Full Text] [Related]
9. D-SP5 Peptide-Modified Highly Branched Polyethylenimine for Gene Therapy of Gastric Adenocarcinoma.
Li X; Xie Z; Xie C; Lu W; Gao C; Ren H; Ying M; Wei X; Gao J; Su B; Ren Y; Liu M
Bioconjug Chem; 2015 Aug; 26(8):1494-503. PubMed ID: 26052814
[TBL] [Abstract][Full Text] [Related]
10. [Effect of nanosize delivery system for ASODN against hTERT on the expression of telomerase in the esophageal cancer EC9706 cells].
Wang J; Zhang ZZ; Zhou TY; Liu YQ; Li HX
Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):566-72. PubMed ID: 19102931
[TBL] [Abstract][Full Text] [Related]
11. TRAIL-secreting human mesenchymal stem cells engineered by a non-viral vector and photochemical internalization for pancreatic cancer gene therapy.
Han J; Hwang HS; Na K
Biomaterials; 2018 Nov; 182():259-268. PubMed ID: 30142525
[TBL] [Abstract][Full Text] [Related]
12. [Inhibition of proliferation of salivary adenoid cystic carcinoma by targeting gene transfer].
Su T; Sun HC; Zang GX; Zhang H; Lu DM
Zhonghua Kou Qiang Yi Xue Za Zhi; 2007 Mar; 42(3):184-5. PubMed ID: 17565833
[TBL] [Abstract][Full Text] [Related]
13. Egr1/HSP70 Promoter-Driven Activation of Gene Expression for Synergistic Anti-Hepatoma Using PEI-MZF Nanoparticles and Radiation.
Zhang J; Dong M; Feng Y; Zhang D; Lin M; Yuan C; Li H; Wang L; Zhang H; Liang C
Int J Nanomedicine; 2022; 17():423-441. PubMed ID: 35115776
[TBL] [Abstract][Full Text] [Related]
14. TRAIL induces apoptosis in oral squamous carcinoma cells--a crosstalk with oncogenic Ras regulated cell surface expression of death receptor 5.
Chen JJ; Mikelis CM; Zhang Y; Gutkind JS; Zhang B
Oncotarget; 2013 Feb; 4(2):206-17. PubMed ID: 23470485
[TBL] [Abstract][Full Text] [Related]
15. Study on the targeted therapy of oral squamous cell carcinoma with a plasmid expressing PE38KDEL toxin under control of the SERPINB3 promoter.
Wu J; Guo Q; Zhang G; Zhao L; Lv Y; Wang J; Liu J; Shi W
Cancer Med; 2020 Mar; 9(6):2213-2222. PubMed ID: 32017381
[TBL] [Abstract][Full Text] [Related]
16. A TRAIL-Delivered Lipoprotein-Bioinspired Nanovector Engineering Stem Cell-Based Platform for Inhibition of Lung Metastasis of Melanoma.
Chen K; Cao X; Li M; Su Y; Li H; Xie M; Zhang Z; Gao H; Xu X; Han Y; Zhou J; Wang W
Theranostics; 2019; 9(10):2984-2998. PubMed ID: 31244937
[TBL] [Abstract][Full Text] [Related]
17. Mesenchymal stem cells as a novel carrier for targeted delivery of gene in cancer therapy based on nonviral transfection.
Hu YL; Huang B; Zhang TY; Miao PH; Tang GP; Tabata Y; Gao JQ
Mol Pharm; 2012 Sep; 9(9):2698-709. PubMed ID: 22862421
[TBL] [Abstract][Full Text] [Related]
18. Systemic delivery and activation of the
Alvizo-Baez CA; Luna-Cruz IE; Vilches-Cisneros N; Rodríguez-Padilla C; Alcocer-González JM
Int J Nanomedicine; 2016; 11():6449-6458. PubMed ID: 27980403
[TBL] [Abstract][Full Text] [Related]
19. Magnetic iron oxide nanoparticles mediated gene therapy for breast cancer--an in vitro study.
Wei W; Xu C; Wu H
J Huazhong Univ Sci Technolog Med Sci; 2006; 26(6):728-30. PubMed ID: 17357502
[TBL] [Abstract][Full Text] [Related]
20. Effects of tumor necrosis factor-related apoptosis-inducing ligand alone and in combination with fluoropyrimidine anticancer agent, S-1, on tumor growth of human oral squamous cell carcinoma xenografts in nude mice.
Itashiki Y; Harada K; Ferdous T; Yoshida H
Anticancer Res; 2007; 27(4B):2365-75. PubMed ID: 17695527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
